Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Nerofe (84AA-API 14AA)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Immune System Key

Drug class:

Apoptosis stimulant, Angiogenesis inhibitor, Immunomodulator

Related drugs:

‹

lurbinectedin (11)

arsenic trioxide (6)

omacetaxine mepesuccinate (4)

quaratusugene ozeplasmid (3)

teserpaturev (1)

ABI-1968 topical cream (0)

autologous γδ T lymphocytes (0)

alpha-tocopheroloxyacetic acid (0)

darinaparsin (0)

elemene injection (0)

BS-HH-002.SA (0)

SIBP-04 (bevacizumab biosimilar) (1)

defibrotide (0)

sonepcizumab (0)

hydroxychloroquine (7)

SQZ-AAC-HPV (1)

HLA-matched donor mononuclear enriched leukocytes (0)

rimiducid activated rivogenlecleucel (0)

GB221 (trastuzumab biosimilar) (0)

GSK2302024A (0)

MVA-BN-HER2 (0)

nelipepimut-S (0)

engineered donor allograft cell therapy (0)

parvovirus H-1 (0)

FT1050+FT4145 programmed mPB (0)

allodepleted T-cell immunotherapeutics (0)

TAEK-VAC-HerBy vaccine (0)

Undisclosed CISH inactivated TIL (0)

thymalfasin (0)

chlorogenic acid (0)

dendritic cell activation therapy (0)

›